APO Research
Talk to an analyst

APO RESEARCH · REPORT

Polyinosinic-polycytidylic Acid Injection

Compare research editions
View pricing & licenses

Selected research

Industry Research

Polyinosinic-polycytidylic Acid Injection Industry Research Report 2026

28 December 2025127 pages

Choose your research edition.

Industry ResearchPolyinosinic-polycytidylic Acid Injection Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Polyinosinic-polycytidylic Acid Injection Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Polyinosinic-polycytidylic Acid Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Polyinosinic-polycytidylic Acid Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Polyinosinic-polycytidylic Acid Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Polyinosinic-polycytidylic Acid Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Polyinosinic-polycytidylic Acid Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Polyinosinic-polycytidylic Acid Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Polyinosinic-polycytidylic Acid Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Polyinosinic-polycytidylic Acid Injection include Zhejiang Ruixin Pharmaceuticals, Tianjin Biochemical Pharmaceuticals, Shuanghe Pharmaceuticals, Jiangsu Langou Pharmaceuticals, Hunan Yige Pharmaceuticals, Haitong Pharmaceuticals, Greenfield (Jiangsu) Pharmaceuticals, Chengdu Tiantaishan Pharmaceutical and Bai Nian Hanke Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Polyinosinic-polycytidylic Acid Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Polyinosinic-polycytidylic Acid Injection Market by Company

Zhejiang Ruixin Pharmaceuticals

Tianjin Biochemical Pharmaceuticals

Shuanghe Pharmaceuticals

Jiangsu Langou Pharmaceuticals

Hunan Yige Pharmaceuticals

Haitong Pharmaceuticals

Greenfield (Jiangsu) Pharmaceuticals

Chengdu Tiantaishan Pharmaceutical

Bai Nian Hanke Pharmaceuticals

Baiyunshan Tianxin Pharmaceuticals

Novus Biological

InvivoGen

Biomol

Polyinosinic-polycytidylic Acid Injection Segment by Type

1ML

2ML

Polyinosinic-polycytidylic Acid Injection Segment by Application

Hospital

Clinic

Other

Polyinosinic-polycytidylic Acid Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polyinosinic-polycytidylic Acid Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Polyinosinic-polycytidylic Acid Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polyinosinic-polycytidylic Acid Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Polyinosinic-polycytidylic Acid Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Polyinosinic-polycytidylic Acid Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Polyinosinic-polycytidylic Acid Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Polyinosinic-polycytidylic Acid Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Polyinosinic-polycytidylic Acid Injection Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Polyinosinic-polycytidylic Acid Injection Sales Market Share by Manufacturers (2021-2026) Table 8. Global Polyinosinic-polycytidylic Acid Injection Revenue of Manufacturers (2021-2026) Table 9. Global Polyinosinic-polycytidylic Acid Injection Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Polyinosinic-polycytidylic Acid Injection Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Polyinosinic-polycytidylic Acid Injection Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Polyinosinic-polycytidylic Acid Injection, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Polyinosinic-polycytidylic Acid Injection, Product Type & Application Table 14. Global Polyinosinic-polycytidylic Acid Injection Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Polyinosinic-polycytidylic Acid Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zhejiang Ruixin Pharmaceuticals Company Information Table 19. Zhejiang Ruixin Pharmaceuticals Business Overview Table 20. Zhejiang Ruixin Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Zhejiang Ruixin Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio Table 22. Zhejiang Ruixin Pharmaceuticals Recent Developments Table 23. Tianjin Biochemical Pharmaceuticals Company Information Table 24. Tianjin Biochemical Pharmaceuticals Business Overview Table 25. Tianjin Biochemical Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Tianjin Biochemical Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio Table 27. Tianjin Biochemical Pharmaceuticals Recent Developments Table 28. Shuanghe Pharmaceuticals Company Information Table 29. Shuanghe Pharmaceuticals Business Overview Table 30. Shuanghe Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Shuanghe Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio Table 32. Shuanghe Pharmaceuticals Recent Developments Table 33. Jiangsu Langou Pharmaceuticals Company Information Table 34. Jiangsu Langou Pharmaceuticals Business Overview Table 35. Jiangsu Langou Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Jiangsu Langou Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio Table 37. Jiangsu Langou Pharmaceuticals Recent Developments Table 38. Hunan Yige Pharmaceuticals Company Information Table 39. Hunan Yige Pharmaceuticals Business Overview Table 40. Hunan Yige Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Hunan Yige Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio Table 42. Hunan Yige Pharmaceuticals Recent Developments Table 43. Haitong Pharmaceuticals Company Information Table 44. Haitong Pharmaceuticals Business Overview Table 45. Haitong Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Haitong Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio Table 47. Haitong Pharmaceuticals Recent Developments Table 48. Greenfield (Jiangsu) Pharmaceuticals Company Information Table 49. Greenfield (Jiangsu) Pharmaceuticals Business Overview Table 50. Greenfield (Jiangsu) Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Greenfield (Jiangsu) Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio Table 52. Greenfield (Jiangsu) Pharmaceuticals Recent Developments Table 53. Chengdu Tiantaishan Pharmaceutical Company Information Table 54. Chengdu Tiantaishan Pharmaceutical Business Overview Table 55. Chengdu Tiantaishan Pharmaceutical Polyinosinic-polycytidylic Acid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Chengdu Tiantaishan Pharmaceutical Polyinosinic-polycytidylic Acid Injection Product Portfolio Table 57. Chengdu Tiantaishan Pharmaceutical Recent Developments Table 58. Bai Nian Hanke Pharmaceuticals Company Information Table 59. Bai Nian Hanke Pharmaceuticals Business Overview Table 60. Bai Nian Hanke Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Bai Nian Hanke Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio Table 62. Bai Nian Hanke Pharmaceuticals Recent Developments Table 63. Baiyunshan Tianxin Pharmaceuticals Company Information Table 64. Baiyunshan Tianxin Pharmaceuticals Business Overview Table 65. Baiyunshan Tianxin Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Baiyunshan Tianxin Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio Table 67. Baiyunshan Tianxin Pharmaceuticals Recent Developments Table 68. Novus Biological Company Information Table 69. Novus Biological Business Overview Table 70. Novus Biological Polyinosinic-polycytidylic Acid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Novus Biological Polyinosinic-polycytidylic Acid Injection Product Portfolio Table 72. Novus Biological Recent Developments Table 73. InvivoGen Company Information Table 74. InvivoGen Business Overview Table 75. InvivoGen Polyinosinic-polycytidylic Acid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. InvivoGen Polyinosinic-polycytidylic Acid Injection Product Portfolio Table 77. InvivoGen Recent Developments Table 78. Biomol Company Information Table 79. Biomol Business Overview Table 80. Biomol Polyinosinic-polycytidylic Acid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Biomol Polyinosinic-polycytidylic Acid Injection Product Portfolio Table 82. Biomol Recent Developments Table 83. Global Polyinosinic-polycytidylic Acid Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 84. Global Polyinosinic-polycytidylic Acid Injection Sales by Region (2021-2026) & (K Units) Table 85. Global Polyinosinic-polycytidylic Acid Injection Sales Market Share by Region (2021-2026) Table 86. Global Polyinosinic-polycytidylic Acid Injection Sales by Region (2027-2032) & (K Units) Table 87. Global Polyinosinic-polycytidylic Acid Injection Sales Market Share by Region (2027-2032) Table 88. Global Polyinosinic-polycytidylic Acid Injection Revenue by Region (2021-2026) & (US$ Million) Table 89. Global Polyinosinic-polycytidylic Acid Injection Revenue Market Share by Region (2021-2026) Table 90. Global Polyinosinic-polycytidylic Acid Injection Revenue by Region (2027-2032) & (US$ Million) Table 91. Global Polyinosinic-polycytidylic Acid Injection Revenue Market Share by Region (2027-2032) Table 92. North America Polyinosinic-polycytidylic Acid Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. North America Polyinosinic-polycytidylic Acid Injection Sales by Country (2021-2026) & (K Units) Table 94. North America Polyinosinic-polycytidylic Acid Injection Sales by Country (2027-2032) & (K Units) Table 95. North America Polyinosinic-polycytidylic Acid Injection Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Polyinosinic-polycytidylic Acid Injection Revenue by Country (2027-2032) & (US$ Million) Table 97. Europe Polyinosinic-polycytidylic Acid Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Europe Polyinosinic-polycytidylic Acid Injection Sales by Country (2021-2026) & (K Units) Table 99. Europe Polyinosinic-polycytidylic Acid Injection Sales by Country (2027-2032) & (K Units) Table 100. Europe Polyinosinic-polycytidylic Acid Injection Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Polyinosinic-polycytidylic Acid Injection Revenue by Country (2027-2032) & (US$ Million) Table 102. Asia Pacific Polyinosinic-polycytidylic Acid Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Asia Pacific Polyinosinic-polycytidylic Acid Injection Sales by Country (2021-2026) & (K Units) Table 104. Asia Pacific Polyinosinic-polycytidylic Acid Injection Sales by Country (2027-2032) & (K Units) Table 105. Asia Pacific Polyinosinic-polycytidylic Acid Injection Revenue by Country (2021-2026) & (US$ Million) Table 106. Asia Pacific Polyinosinic-polycytidylic Acid Injection Revenue by Country (2027-2032) & (US$ Million) Table 107. South America Polyinosinic-polycytidylic Acid Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. South America Polyinosinic-polycytidylic Acid Injection Sales by Country (2021-2026) & (K Units) Table 109. South America Polyinosinic-polycytidylic Acid Injection Sales by Country (2027-2032) & (K Units) Table 110. South America Polyinosinic-polycytidylic Acid Injection Revenue by Country (2021-2026) & (US$ Million) Table 111. South America Polyinosinic-polycytidylic Acid Injection Revenue by Country (2027-2032) & (US$ Million) Table 112. Middle East and Africa Polyinosinic-polycytidylic Acid Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Middle East and Africa Polyinosinic-polycytidylic Acid Injection Sales by Country (2021-2026) & (K Units) Table 114. Middle East and Africa Polyinosinic-polycytidylic Acid Injection Sales by Country (2027-2032) & (K Units) Table 115. Middle East and Africa Polyinosinic-polycytidylic Acid Injection Revenue by Country (2021-2026) & (US$ Million) Table 116. Middle East and Africa Polyinosinic-polycytidylic Acid Injection Revenue by Country (2027-2032) & (US$ Million) Table 117. Global Polyinosinic-polycytidylic Acid Injection Sales by Type (2021-2026) & (K Units) Table 118. Global Polyinosinic-polycytidylic Acid Injection Sales by Type (2027-2032) & (K Units) Table 119. Global Polyinosinic-polycytidylic Acid Injection Sales Market Share by Type (2021-2026) Table 120. Global Polyinosinic-polycytidylic Acid Injection Sales Market Share by Type (2027-2032) Table 121. Global Polyinosinic-polycytidylic Acid Injection Revenue by Type (2021-2026) & (US$ Million) Table 122. Global Polyinosinic-polycytidylic Acid Injection Revenue by Type (2027-2032) & (US$ Million) Table 123. Global Polyinosinic-polycytidylic Acid Injection Revenue Market Share by Type (2021-2026) Table 124. Global Polyinosinic-polycytidylic Acid Injection Revenue Market Share by Type (2027-2032) Table 125. Global Polyinosinic-polycytidylic Acid Injection Price by Type (2021-2026) & (US$/Unit) Table 126. Global Polyinosinic-polycytidylic Acid Injection Price by Type (2027-2032) & (US$/Unit) Table 127. Global Polyinosinic-polycytidylic Acid Injection Sales by Application (2021-2026) & (K Units) Table 128. Global Polyinosinic-polycytidylic Acid Injection Sales by Application (2027-2032) & (K Units) Table 129. Global Polyinosinic-polycytidylic Acid Injection Sales Market Share by Application (2021-2026) Table 130. Global Polyinosinic-polycytidylic Acid Injection Sales Market Share by Application (2027-2032) Table 131. Global Polyinosinic-polycytidylic Acid Injection Revenue by Application (2021-2026) & (US$ Million) Table 132. Global Polyinosinic-polycytidylic Acid Injection Revenue by Application (2027-2032) & (US$ Million) Table 133. Global Polyinosinic-polycytidylic Acid Injection Revenue Market Share by Application (2021-2026) Table 134. Global Polyinosinic-polycytidylic Acid Injection Revenue Market Share by Application (2027-2032) Table 135. Global Polyinosinic-polycytidylic Acid Injection Price by Application (2021-2026) & (US$/Unit) Table 136. Global Polyinosinic-polycytidylic Acid Injection Price by Application (2027-2032) & (US$/Unit) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Polyinosinic-polycytidylic Acid Injection Distributors List Table 140. Polyinosinic-polycytidylic Acid Injection Customers List Table 141. Polyinosinic-polycytidylic Acid Injection Industry Trends Table 142. Polyinosinic-polycytidylic Acid Injection Industry Drivers Table 143. Polyinosinic-polycytidylic Acid Injection Industry Restraints Table 144. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Polyinosinic-polycytidylic Acid Injection Product Image Figure 5. Global Polyinosinic-polycytidylic Acid Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Polyinosinic-polycytidylic Acid Injection Market Size (2021-2032) & (US$ Million) Figure 7. Global Polyinosinic-polycytidylic Acid Injection Sales (2021-2032) & (K Units) Figure 8. Global Polyinosinic-polycytidylic Acid Injection Average Price (US$/Unit) & (2021-2032) Figure 9. 1ML Product Image Figure 10. 2ML Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Other Product Image Figure 14. Global Polyinosinic-polycytidylic Acid Injection Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Polyinosinic-polycytidylic Acid Injection, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Polyinosinic-polycytidylic Acid Injection Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Polyinosinic-polycytidylic Acid Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Polyinosinic-polycytidylic Acid Injection Sales by Region in 2025 Figure 20. Global Polyinosinic-polycytidylic Acid Injection Revenue by Region in 2025 Figure 21. North America Polyinosinic-polycytidylic Acid Injection Market Size by Country in 2025 Figure 22. North America Polyinosinic-polycytidylic Acid Injection Sales Market Share by Country (2021-2032) Figure 23. North America Polyinosinic-polycytidylic Acid Injection Revenue Market Share by Country (2021-2032) Figure 24. United States Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Polyinosinic-polycytidylic Acid Injection Market Size by Country in 2025 Figure 28. Europe Polyinosinic-polycytidylic Acid Injection Sales Market Share by Country (2021-2032) Figure 29. Europe Polyinosinic-polycytidylic Acid Injection Revenue Market Share by Country (2021-2032) Figure 30. Germany Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Polyinosinic-polycytidylic Acid Injection Market Size by Country in 2025 Figure 41. Asia Pacific Polyinosinic-polycytidylic Acid Injection Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Polyinosinic-polycytidylic Acid Injection Revenue Market Share by Country (2021-2032) Figure 43. China Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Polyinosinic-polycytidylic Acid Injection Market Size by Country in 2025 Figure 52. South America Polyinosinic-polycytidylic Acid Injection Sales Market Share by Country (2021-2032) Figure 53. South America Polyinosinic-polycytidylic Acid Injection Revenue Market Share by Country (2021-2032) Figure 54. Brazil Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Polyinosinic-polycytidylic Acid Injection Market Size by Country in 2025 Figure 58. Middle East and Africa Polyinosinic-polycytidylic Acid Injection Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Polyinosinic-polycytidylic Acid Injection Revenue Market Share by Country (2021-2032) Figure 60. Egypt Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Polyinosinic-polycytidylic Acid Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Polyinosinic-polycytidylic Acid Injection Sales Market Share by Type (2021-2032) Figure 66. Global Polyinosinic-polycytidylic Acid Injection Revenue Market Share by Type (2021-2032) Figure 67. Global Polyinosinic-polycytidylic Acid Injection Price (US$/Unit) by Type (2021-2032) Figure 68. Global Polyinosinic-polycytidylic Acid Injection Sales Market Share by Application (2021-2032) Figure 69. Global Polyinosinic-polycytidylic Acid Injection Revenue Market Share by Application (2021-2032) Figure 70. Global Polyinosinic-polycytidylic Acid Injection Price (US$/Unit) by Application (2021-2032) Figure 71. Polyinosinic-polycytidylic Acid Injection Value Chain Figure 72. Polyinosinic-polycytidylic Acid Injection Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Polyinosinic-polycytidylic Acid Injection Industry Opportunities and Challenges

Scope & coverage.

Types
  • 1ML
  • 2ML
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Zhejiang Ruixin Pharmaceuticals
  • Tianjin Biochemical Pharmaceuticals
  • Shuanghe Pharmaceuticals
  • Jiangsu Langou Pharmaceuticals
  • Hunan Yige Pharmaceuticals
  • Haitong Pharmaceuticals
  • Greenfield (Jiangsu) Pharmaceuticals
  • Chengdu Tiantaishan Pharmaceutical
  • Bai Nian Hanke Pharmaceuticals
  • Baiyunshan Tianxin Pharmaceuticals
  • Novus Biological
  • InvivoGen
  • Biomol

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Polyinosinic-polycytidylic Acid Injection Market Size (2021-2032)
  4. 2.2.2 Global Polyinosinic-polycytidylic Acid Injection Sales (2021-2032)
  5. 2.2.3 Global Polyinosinic-polycytidylic Acid Injection Market Average Price (2021-2032)
  6. 2.3 Polyinosinic-polycytidylic Acid Injection by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 1ML
  9. 2.3.3 2ML
  10. 2.4 Polyinosinic-polycytidylic Acid Injection by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Polyinosinic-polycytidylic Acid Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Polyinosinic-polycytidylic Acid Injection Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Polyinosinic-polycytidylic Acid Injection Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Polyinosinic-polycytidylic Acid Injection Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Polyinosinic-polycytidylic Acid Injection Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Polyinosinic-polycytidylic Acid Injection, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Polyinosinic-polycytidylic Acid Injection, Product Type & Application
  8. 3.8 Global Manufacturers of Polyinosinic-polycytidylic Acid Injection, Established Date
  9. 3.9 Global Polyinosinic-polycytidylic Acid Injection Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zhejiang Ruixin Pharmaceuticals
  2. 4.1.1 Zhejiang Ruixin Pharmaceuticals Company Information
  3. 4.1.2 Zhejiang Ruixin Pharmaceuticals Business Overview
  4. 4.1.3 Zhejiang Ruixin Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zhejiang Ruixin Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio
  6. 4.1.5 Zhejiang Ruixin Pharmaceuticals Recent Developments
  7. 4.2 Tianjin Biochemical Pharmaceuticals
  8. 4.2.1 Tianjin Biochemical Pharmaceuticals Company Information
  9. 4.2.2 Tianjin Biochemical Pharmaceuticals Business Overview
  10. 4.2.3 Tianjin Biochemical Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Tianjin Biochemical Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio
  12. 4.2.5 Tianjin Biochemical Pharmaceuticals Recent Developments
  13. 4.3 Shuanghe Pharmaceuticals
  14. 4.3.1 Shuanghe Pharmaceuticals Company Information
  15. 4.3.2 Shuanghe Pharmaceuticals Business Overview
  16. 4.3.3 Shuanghe Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Shuanghe Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio
  18. 4.3.5 Shuanghe Pharmaceuticals Recent Developments
  19. 4.4 Jiangsu Langou Pharmaceuticals
  20. 4.4.1 Jiangsu Langou Pharmaceuticals Company Information
  21. 4.4.2 Jiangsu Langou Pharmaceuticals Business Overview
  22. 4.4.3 Jiangsu Langou Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Jiangsu Langou Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio
  24. 4.4.5 Jiangsu Langou Pharmaceuticals Recent Developments
  25. 4.5 Hunan Yige Pharmaceuticals
  26. 4.5.1 Hunan Yige Pharmaceuticals Company Information
  27. 4.5.2 Hunan Yige Pharmaceuticals Business Overview
  28. 4.5.3 Hunan Yige Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Hunan Yige Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio
  30. 4.5.5 Hunan Yige Pharmaceuticals Recent Developments
  31. 4.6 Haitong Pharmaceuticals
  32. 4.6.1 Haitong Pharmaceuticals Company Information
  33. 4.6.2 Haitong Pharmaceuticals Business Overview
  34. 4.6.3 Haitong Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Haitong Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio
  36. 4.6.5 Haitong Pharmaceuticals Recent Developments
  37. 4.7 Greenfield (Jiangsu) Pharmaceuticals
  38. 4.7.1 Greenfield (Jiangsu) Pharmaceuticals Company Information
  39. 4.7.2 Greenfield (Jiangsu) Pharmaceuticals Business Overview
  40. 4.7.3 Greenfield (Jiangsu) Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Greenfield (Jiangsu) Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio
  42. 4.7.5 Greenfield (Jiangsu) Pharmaceuticals Recent Developments
  43. 4.8 Chengdu Tiantaishan Pharmaceutical
  44. 4.8.1 Chengdu Tiantaishan Pharmaceutical Company Information
  45. 4.8.2 Chengdu Tiantaishan Pharmaceutical Business Overview
  46. 4.8.3 Chengdu Tiantaishan Pharmaceutical Polyinosinic-polycytidylic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Chengdu Tiantaishan Pharmaceutical Polyinosinic-polycytidylic Acid Injection Product Portfolio
  48. 4.8.5 Chengdu Tiantaishan Pharmaceutical Recent Developments
  49. 4.9 Bai Nian Hanke Pharmaceuticals
  50. 4.9.1 Bai Nian Hanke Pharmaceuticals Company Information
  51. 4.9.2 Bai Nian Hanke Pharmaceuticals Business Overview
  52. 4.9.3 Bai Nian Hanke Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Bai Nian Hanke Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio
  54. 4.9.5 Bai Nian Hanke Pharmaceuticals Recent Developments
  55. 4.10 Baiyunshan Tianxin Pharmaceuticals
  56. 4.10.1 Baiyunshan Tianxin Pharmaceuticals Company Information
  57. 4.10.2 Baiyunshan Tianxin Pharmaceuticals Business Overview
  58. 4.10.3 Baiyunshan Tianxin Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Baiyunshan Tianxin Pharmaceuticals Polyinosinic-polycytidylic Acid Injection Product Portfolio
  60. 4.10.5 Baiyunshan Tianxin Pharmaceuticals Recent Developments
  61. 4.11 Novus Biological
  62. 4.11.1 Novus Biological Company Information
  63. 4.11.2 Novus Biological Business Overview
  64. 4.11.3 Novus Biological Polyinosinic-polycytidylic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Novus Biological Polyinosinic-polycytidylic Acid Injection Product Portfolio
  66. 4.11.5 Novus Biological Recent Developments
  67. 4.12 InvivoGen
  68. 4.12.1 InvivoGen Company Information
  69. 4.12.2 InvivoGen Business Overview
  70. 4.12.3 InvivoGen Polyinosinic-polycytidylic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 InvivoGen Polyinosinic-polycytidylic Acid Injection Product Portfolio
  72. 4.12.5 InvivoGen Recent Developments
  73. 4.13 Biomol
  74. 4.13.1 Biomol Company Information
  75. 4.13.2 Biomol Business Overview
  76. 4.13.3 Biomol Polyinosinic-polycytidylic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Biomol Polyinosinic-polycytidylic Acid Injection Product Portfolio
  78. 4.13.5 Biomol Recent Developments
5 Global Polyinosinic-polycytidylic Acid Injection Market Scenario by Region
  1. 5.1 Global Polyinosinic-polycytidylic Acid Injection Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Polyinosinic-polycytidylic Acid Injection Sales by Region: 2021-2032
  3. 5.2.1 Global Polyinosinic-polycytidylic Acid Injection Sales by Region: 2021-2026
  4. 5.2.2 Global Polyinosinic-polycytidylic Acid Injection Sales by Region: 2027-2032
  5. 5.3 Global Polyinosinic-polycytidylic Acid Injection Revenue by Region: 2021-2032
  6. 5.3.1 Global Polyinosinic-polycytidylic Acid Injection Revenue by Region: 2021-2026
  7. 5.3.2 Global Polyinosinic-polycytidylic Acid Injection Revenue by Region: 2027-2032
  8. 5.4 North America Polyinosinic-polycytidylic Acid Injection Market Facts & Figures by Country
  9. 5.4.1 North America Polyinosinic-polycytidylic Acid Injection Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Polyinosinic-polycytidylic Acid Injection Sales by Country (2021-2032)
  11. 5.4.3 North America Polyinosinic-polycytidylic Acid Injection Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Polyinosinic-polycytidylic Acid Injection Market Facts & Figures by Country
  16. 5.5.1 Europe Polyinosinic-polycytidylic Acid Injection Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Polyinosinic-polycytidylic Acid Injection Sales by Country (2021-2032)
  18. 5.5.3 Europe Polyinosinic-polycytidylic Acid Injection Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Polyinosinic-polycytidylic Acid Injection Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Polyinosinic-polycytidylic Acid Injection Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Polyinosinic-polycytidylic Acid Injection Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Polyinosinic-polycytidylic Acid Injection Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Polyinosinic-polycytidylic Acid Injection Market Facts & Figures by Country
  41. 5.7.1 South America Polyinosinic-polycytidylic Acid Injection Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Polyinosinic-polycytidylic Acid Injection Sales by Country (2021-2032)
  43. 5.7.3 South America Polyinosinic-polycytidylic Acid Injection Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Polyinosinic-polycytidylic Acid Injection Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Polyinosinic-polycytidylic Acid Injection Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Polyinosinic-polycytidylic Acid Injection Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Polyinosinic-polycytidylic Acid Injection Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Polyinosinic-polycytidylic Acid Injection Sales by Type (2021-2032)
  2. 6.1.1 Global Polyinosinic-polycytidylic Acid Injection Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Polyinosinic-polycytidylic Acid Injection Sales Market Share by Type (2021-2032)
  4. 6.2 Global Polyinosinic-polycytidylic Acid Injection Revenue by Type (2021-2032)
  5. 6.2.1 Global Polyinosinic-polycytidylic Acid Injection Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Polyinosinic-polycytidylic Acid Injection Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Polyinosinic-polycytidylic Acid Injection Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Polyinosinic-polycytidylic Acid Injection Sales by Application (2021-2032)
  2. 7.1.1 Global Polyinosinic-polycytidylic Acid Injection Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Polyinosinic-polycytidylic Acid Injection Sales Market Share by Application (2021-2032)
  4. 7.2 Global Polyinosinic-polycytidylic Acid Injection Revenue by Application (2021-2032)
  5. 7.2.1 Global Polyinosinic-polycytidylic Acid Injection Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Polyinosinic-polycytidylic Acid Injection Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Polyinosinic-polycytidylic Acid Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Polyinosinic-polycytidylic Acid Injection Value Chain Analysis
  2. 8.1.1 Polyinosinic-polycytidylic Acid Injection Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Polyinosinic-polycytidylic Acid Injection Production Mode & Process
  5. 8.2 Polyinosinic-polycytidylic Acid Injection Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Polyinosinic-polycytidylic Acid Injection Distributors
  8. 8.2.3 Polyinosinic-polycytidylic Acid Injection Customers
9 Global Polyinosinic-polycytidylic Acid Injection Analyzing Market Dynamics
  1. 9.1 Polyinosinic-polycytidylic Acid Injection Industry Trends
  2. 9.2 Polyinosinic-polycytidylic Acid Injection Industry Drivers
  3. 9.3 Polyinosinic-polycytidylic Acid Injection Industry Opportunities and Challenges
  4. 9.4 Polyinosinic-polycytidylic Acid Injection Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst